Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products

Lancet Infect Dis. 2021 Jun;21(6):765-766. doi: 10.1016/S1473-3099(21)00059-1. Epub 2021 Feb 16.

Authors

Carolina Romero¹, José María Díez², Rodrigo Gajardo²

Affiliations

¹ Immunotherapies Unit, Bioscience Research & Development, Scientific Innovation Office, Grifols, Barcelona, Spain. Electronic address: carolina.romero@grifols.com.
² Immunotherapies Unit, Bioscience Research & Development, Scientific Innovation Office, Grifols, Barcelona, Spain.

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Viral / immunology*
Blood Donors*
COVID-19 / immunology
COVID-19 Drug Treatment*
Humans
Immunoglobulin G
Immunoglobulins, Intravenous / therapeutic use*
Plasma*
SARS-CoV-2 / immunology

Substances

Antibodies, Viral
Immunoglobulin G
Immunoglobulins, Intravenous